One plaintiff’s lawsuit in Louisiana federal court over allegations that diabetes drug Actos increases the risk of bladder cancer resulted in a $9 billion verdict. What might a jury do in a case consolidating claims by two plaintiffs?
Takeda Pharmaceuticals America Inc. is at trial over combined claims by Delores Cipriano and Bertha Triana, who allege they received inadequate warnings about Actos. Cipriano’s attorney, Robert Eglet, said he plans to seek a multibillion-dollar verdict, the Las Vegas Review Journal reported.
